Xlife Sciences Past Earnings Performance
Past criteria checks 4/6
Xlife Sciences has been growing earnings at an average annual rate of 10.8%, while the Life Sciences industry saw earnings growing at 12.3% annually. Revenues have been growing at an average rate of 14.1% per year. Xlife Sciences's return on equity is 4.3%, and it has net margins of 2144.5%.
Key information
10.8%
Earnings growth rate
4.3%
EPS growth rate
Life Sciences Industry Growth | 17.6% |
Revenue growth rate | 14.1% |
Return on equity | 4.3% |
Net Margin | 2,144.5% |
Next Earnings Update | 25 Apr 2025 |
Revenue & Expenses Breakdown
How Xlife Sciences makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Jun 24 | 1 | 21 | 3 | 0 |
31 Mar 24 | 1 | 18 | 4 | 0 |
31 Dec 23 | 1 | 15 | 5 | 0 |
30 Sep 23 | 1 | 16 | 5 | 0 |
30 Jun 23 | 1 | 16 | 6 | 0 |
31 Mar 23 | 1 | 15 | 6 | 0 |
31 Dec 22 | 1 | 14 | 5 | 0 |
30 Sep 22 | 1 | 32 | 5 | 0 |
30 Jun 22 | 1 | 49 | 5 | 0 |
31 Mar 22 | 1 | 51 | 6 | 0 |
31 Dec 21 | 1 | 53 | 6 | 0 |
30 Sep 21 | 1 | 34 | 5 | 0 |
30 Jun 21 | 1 | 14 | 5 | 0 |
31 Mar 21 | 0 | 18 | 4 | 0 |
31 Dec 20 | 0 | 21 | 3 | 0 |
30 Sep 20 | 0 | 14 | 2 | 0 |
30 Jun 20 | 1 | 6 | 2 | 0 |
31 Mar 20 | 1 | 3 | 1 | 0 |
31 Dec 19 | 1 | 1 | 1 | 0 |
Quality Earnings: XLS has a large one-off gain of CHF38.6M impacting its last 12 months of financial results to 30th June, 2024.
Growing Profit Margin: XLS's current net profit margins are higher than last year .
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: XLS's earnings have grown by 10.8% per year over the past 5 years.
Accelerating Growth: XLS's earnings growth over the past year (31.7%) exceeds its 5-year average (10.8% per year).
Earnings vs Industry: XLS earnings growth over the past year (31.7%) exceeded the Life Sciences industry 4.3%.
Return on Equity
High ROE: XLS's Return on Equity (4.3%) is considered low.